Structure, chromosomal localization, and expression of 12 genes of the MAGE family

Anichini, A., Fossati, G., and Parmiani, G. Clonal analysis of the cytolytic T -cell response to human tumors.Immunol Today 8: 385?389, 1987

Brasseur, F., Marchand, M., Vanwijck, R., Hérin, M., Lethé, B., Chomez, P., and Boon, T. Human gene MAGE-1, which codes for a tumor rejection antigen, is expressed by some breast tumors.Int J Cancer 52: 839?841, 1992

De Smet, C., Lurquin, C., van der Bruggen, P., De Plaen, E., Brasseur, F., and Boon, T. Sequence and expression pattern of the human MAGE2 gene.Immunogenetics 39: 121?129, 1994

Falk, K., Rötzschke, O., Stevanovic, S., Jung, G., and Rammensee, H. -G. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules.Nature 351: 290?296, 1991

Gaboriaud, C., Bissery, V., Benchetrit, T., and Mornon, J. P. Hydrophobic cluster analysis: an efficient new way to compare and analyse amino acid sequences.FEBS Lett 224: 149?155, 1987

Gaugler, B., van den Eynde, B., van der Bruggen, P., Romero, P., Gaforio, J. J., De Plaen, E., Lethé, B., Brasseur, F., and Boon, T. Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes.J Exp Med 179: 921?930, 1994

Hérin, M., Lemoine, C., Weynants, P., Vessière, E., Van Pel, A., Knuth, A., Devos, R., and Boon, T. Production of stable cytolytic T-cell clones directed against autologous human melanoma.Int J Cancer 39: 390?396, 1987

Hill, A. V. S., Elvin, J., Willis, A. C., Aidoo, M., Allsopp, C. E. M., Gotch, F. M., Gao, X. M., Takiguchi, M., Greenwood, B. M., Townsend, A. R. M., and McMichael, A. J. Molecular analysis of the association of HLA-B53 and resistance to severe malaria.Nature 360: 434?439, 1992

Houbiers, J. G. A., Nijman, H. W., van der Burg, S. H., Drijfhout, J. W., Kenemans, P., van de Velde, C. J. H., Brand, A., Momburg, F., Kast, M. W., and Melief, C. J. M. In vitro induction of human cytotoxic T lymphocyte responses against peptides of mutant and wild-type p53.Eur J Immunol 23: 2072?2077, 1993

James, C. D., Carlbom, E., Dumanski, J. P., Hansen, M., Nordenskjold, M., Collins, V. P., and Cavenee, W. K. Clonal genomic alterations in glioma malignancy stages.Cancer Res 48: 5546?5551, 1988

Jardetzky, T. S., Lane, W. S., Robinson, R. A., Madden, D. R., and Wiley, D. C. Identification of self peptides bound to purified HLAB27.Nature 353: 326?329, 1991

Knuth, A., Danowski, B., Oettgen, H. F., and Old, L. T-cell mediated cytotoxicity against autologous malignant melanoma: analysis with interleukin-2-dependent T-cell cultures.Proc Natl Acad Sci USA 81: 3511?3515, 1984

Maruyama, K., Usami, M., Aizawa, T., and Yoshikawa, K. A novel brain-specific mRNA encoding nuclear protein (necdin) expressed in neurally differentiated embryonal carcinoma cells.Biochem Biophys Res Commun 178: 291?296, 1991

McMichael, A. J., Gotch, F. M., and Rothbard, J. HLA B37 determines an influenza A virus nucleoprotein epitope recognized by cytotoxic T lymphocytes.J Exp Med 164: 1397?1406, 1986

Mukherji, B. and MacAlister, T. J. Clonal analysis of cytotoxic T cell response against human melanoma.J Exp Med 158: 240?245, 1983

Taylor, P. M., Davey, J., Howland, K., Rothbard, J. B., and Askonas, B. A. Class I MHC molecules rather than other mouse genes dictate influenza epitope recognition by cytotoxic T cells.Immunogenetics 26: 267?272, 1987

Traversari, C., van der Bruggen, P., Luescher, I. F., Lurquin, C., Chomez, P., Van Pel, A, De Plaen, E., Amar-Costesec, A., and Boon, T. A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E.J Exp Med 176: 1453?1457, 1992a

Traversari, C., van der Bruggen, P., Van den Eynde, B., Hainaut, P., Lemoine, C., Ohta, N., Old, L., and Boon, T. Transfection and expression of a gene coding for a human melanoma antigen recognized by autologous cytolytic T lymphocytes.Immunogenetics 35: 145?152, 1992b

Van den Eynde, B., Hainaut, P., Hérin, M., Knuth, A., Lemoine, C., Weynants, P., van der Bruggen, P., Fauchet, R., and Boon, T. Presence on a human melanoma of multiple antigens recognized by autologous CTL.Int J Cancer 44: 634?640, 1989

Van der Bruggen, P, Szikora, J.-P, Boël, P., Wildmann, C., Somville, M., Sensi, M., and Boon, T. Autologous cytolytic T lymphocytes recognize a MAGE-1 nonapeptide on melanomas expressing HLA-Cw*1601.Eur J Immunol, in press

Van der Bruggen, P., Traversari, C., Chomez, P., Lurquin, C., De Plaen, E., Van den Eynde, B., Knuth, A., and Boon, T. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma.Science 254: 1643?1647, 1991

Weynants, P., Lethé, B., Brasseur, F., Marchand, M., and Boon, T. Expression of MAGE genes by non-small-cell lung carcinomas.Int J Cancer 56: 826?829, 1994